Columbia Care Inc. CCHWF CCHW CCHW 3LP released financial results for the second quarter ended June 30, 2022, revealing revenue of $129.6 million, an 18.1% increase compared to $109.7 million in Q2 2021.
Q2 2022 Financial Highlights
-
Gross profit was $50.8 million, a 17.3% increase compared to $43.3 million in Q2 2021, and a 10.2% decrease compared to Q1 2022.
-
Adjusted EBITDA was $12 million, a decrease of 26.8% compared to adjusted EBITDA of $16.4 million in Q2 2021.
Nicholas Vita, CEO of Columbia Care, stated, “For the remainder of 2022, Columbia Care will execute against our strategic priorities while completing the steps necessary to close the merger with Cresco on time. The integration planning process has brought an overwhelming sense of excitement and momentum. As a founder of Columbia Care, seeing our organizations collaborate so well has been humbling and deeply gratifying. Our shared vision has enabled both organizations to focus on the range of opportunities that lay before us and meet the future with clarity, momentum and capabilities that will drive outsized shareholder value for years to come. The embedded growth and sustainable margin opportunity being unlocked by this combination will be a gamechanger.”
2022 Outlook
Anticipating business and financial reporting impacts and adjustments from the asset divestitures required for the Cresco transaction, ongoing economic headwinds, and assuming no material improvement in Colorado or California, Columbia Care is forecasting continued sequential top line growth of mid-single digits in each of the next two quarters. In addition, the company expects sequential improvements in market level EBITDA margin in the range of 150-250 basis points per quarter compared to its YTD results.
Photo by Esteban Lopez on Unsplash
Related News
Columbia Care Seed & Strain Pre-Rolls Hit New York Cannabis Market
State Lawmakers Call For Federal Marijuana Legalization And Banking Reform
Columbia Care Introduces National Cannabis Loyalty Mobile App Across 14 Markets
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.